Longjun Zang
Overview
Explore the profile of Longjun Zang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen D, Liu P, Lin J, Zang L, Liu Y, Zhai S, et al.
Adv Sci (Weinh)
. 2024 Dec;
12(7):e2406624.
PMID: 39739618
The resistance of tumors to immune checkpoint inhibitors (ICI) may be intricately linked to cellular senescence, although definitive clinical validation remains elusive. In this study, comprehensive pan-cancer scRNA-seq analyses identify...
2.
Chen D, Liu P, Lu X, Li J, Qi D, Zang L, et al.
J Exp Clin Cancer Res
. 2024 Apr;
43(1):125.
PMID: 38664705
Background: Immunotherapy has emerged as a potent clinical approach for cancer treatment, but only subsets of cancer patients can benefit from it. Targeting lactate metabolism (LM) in tumor cells as...
3.
Chen D, Zang L, Zhou Y, Yang Y, Zhang X, Li Z, et al.
Heliyon
. 2024 Mar;
10(6):e28243.
PMID: 38545193
Pancreatic cancer (PC) is a malignant digestive system tumor with a very poor prognosis. N6-methyladenosine (m6A) is mediated by a variety of readers and participates in important regulatory roles in...
4.
Zang L, Zhang B, Zhou Y, Zhang F, Tian X, Tian Z, et al.
Aging (Albany NY)
. 2023 Dec;
15(23):14109-14140.
PMID: 38095640
Pancreatic cancer (PC) is a digestive malignancy with worse overall survival. Tumor immune environment (TIME) alters the progression and proliferation of various solid tumors. Hence, we aimed to detect the...
5.
Chen D, Cao Y, Tang H, Zang L, Yao N, Zhu Y, et al.
Theranostics
. 2023 Jun;
13(10):3290-3309.
PMID: 37351165
: Accumulating evidence illustrated that the reprogramming of the super-enhancers (SEs) landscape could promote the acquisition of metastatic features in pancreatic cancer (PC). Given the anatomy-based TNM staging is limited...
6.
Wang C, Deng Z, Zang L, Shu Y, He S, Wu X
Am J Transl Res
. 2023 Jan;
14(12):8437-8456.
PMID: 36628243
This study aimed to identify author, country, institutional, and journal collaborations and assess their impact, along with knowledge base, as well as identify existing trends, and uncover emerging topics related...
7.
Gao W, Chen D, Liu J, Zang L, Xiao T, Zhang X, et al.
Front Immunol
. 2023 Jan;
13:1031184.
PMID: 36601127
Background: Pancreatic cancer (PC) is one of the most lethal malignancies and carries a dismal mortality and morbidity. Four types of RNA modification (namely m6A, m1A, APA and A-to-I) could...
8.
Huang H, Sun J, Li Z, Zang L, Zhu H, Zhang X, et al.
J Oncol
. 2022 Jun;
2022:7427146.
PMID: 35669237
Background: Comparing the effects of C-shaped embedded anastomosis and pancreatic duct-jejunal mucosal anastomosis on the incidence of pancreatic fistula after pancreaticoduodenectomy (PD) to find a better pancreaticojejunal anastomosis method that...
9.
Chen D, Gao W, Zang L, Zhang X, Li Z, Zhu H, et al.
Front Cell Dev Biol
. 2022 Feb;
10:819724.
PMID: 35223846
Pancreatic cancer (PC) is one of the most lethal malignancies, the mortality and morbidity of which have been increasing over the past decade. Ferroptosis, a newly identified iron-dependent cell death...
10.
Chen D, Liu J, Zang L, Xiao T, Zhang X, Li Z, et al.
Int J Biol Sci
. 2022 Jan;
18(1):360-373.
PMID: 34975338
Immunotherapy has made great progress in hepatocellular carcinoma (HCC), yet there is still a lack of biomarkers for predicting response to it. Cancer stem cells (CSCs) are the primary cause...